What is a randomised controlled trial?
By CS O’Gorman, A. Macken, W. Cullen, J. Saunders, C. Dunne, M. Higgins. Irish medical journal, 2013
854 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/ca12701ceb17f3abfe199ace8f42ebaae6ab1510
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- G. Malhi
- R. Porter
- R. Mulder
- Paul B. Fitzgerald
- G. Murray
- Ajeet B Singh
- H. Horlings
- Richard A. Bryant
Citations in the corpus
- Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance (2019, unknown): “KEYNOTE-010 (ref.(146)) 2 mg/kg, 3-weekly (339) 3 (0.”
- Improved classification of breast cancer by analysis of genetic alterations and gene expression profiling (2011, methodology): “However, using these guidelines, a substantial proportion of breast cancer patients who would also survive without adjuvant systemic therapy undergo systemic therapy and suffer from its side effects without gaining any benefit (28, 29).”
- Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders (2015, background): “In this regard, based on available evidence, lurasidone is preferable (Loebel et al., 2014b; Selle et al., 2014) also because the combination study demonstrating its efficacy has fewer methodological issues.”